Trixone TZ 1000 mg/125 mg Injection
By Trixone TZ
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Flamingo Pharmaceuticals Ltd
7/1, Corporate Park Sion Trombay Road P.O. Box No. 27257 Chembur Mumbai – 400071 , Maharashtra India

Expires on or after
March, 2026

liver
When using Trixone TZ 1000 mg/125 mg Injection, it's important to be cautious if you have severe liver disease. In such cases, the dosage of Trixone TZ 1000 mg/125 mg Injection may need to be adjusted. It's crucial to consult your doctor before starting treatment with Trixone TZ 1000 mg/125 mg Injection if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of Trixone TZ 1000 mg/125 mg Injection is not typically recommended. Always follow your doctor's guidance and advice regarding the use of Trixone TZ 1000 mg/125 mg Injection in relation to your liver health.

kidney
Limited data exists on the use of Trixone TZ 1000 mg/125 mg Injection in people with kidney issues. It's recommended to seek advice from your doctor.

alcohol
When taking Trixone TZ 1000 mg/125 mg Injection, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
Trixone TZ 1000 mg/125 mg Injection may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Trixone TZ 1000 mg/125 mg Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Trixone TZ 1000 mg/125 mg Injection should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹137.59
₹152.88
10% OFF
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024
